This invention relates to stable pharmaceutical compositions for parenteraladministration comprising dopamine agonists and peripheral acting agents.usefulfor treatment of metabolic disorders or key elements thereof. The parenteraldosage forms exhibit long stable shelf life and distinct pharmacokinetics.